Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

PREVENT ALL ALS Study

NCT06581861

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
View all 32 locations
View Trial Details
Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684

Conditions
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Behavioral Variant Frontotemporal Dementia (bvFTD), +41 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 27 locations
View Trial Details
Recruiting

ASSESS ALL ALS Study

NCT06578195

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California, Irvine Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
View all 37 locations
View Trial Details
Recruiting

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

NCT07023835

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Zydus US015 La Jolla, California, United States
  • Zydus US008 Orange, California, United States
  • Zydus US013 San Francisco, California, United States
  • Zydus US005 New Britain, Connecticut, United States
View all 17 locations
View Trial Details
Recruiting

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

NCT07322003

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Recruiting

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

NCT07142291

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Honor Health Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Sutter Health - California Pacific Medical Center Research Institute San Francisco, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 22 locations
View Trial Details

Related conditions